Abilify and Pataday drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Abilify (aripiprazole) and Pataday (olopatadine hydrochloride). Common drug interactions include infusion related reaction among females and anxiety among males.

The phase IV clinical study analyzes what interactions people have when they take Abilify and Pataday. It is created by eHealthMe based on reports of 47 people who take the same drugs from the FDA, and is updated regularly.

What is Abilify?

Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 101,454 Abilify users. Check the latest studies of Abilify.

What is Pataday?

Pataday has active ingredients of olopatadine hydrochloride. It is often used in allergies. eHealthMe is studying from 8,288 Pataday users. Check the latest studies of Pataday.

On Jul, 10, 2026

47 people who take Abilify and Pataday together, and have interactions are studied.

What are the common drug interactions of Abilify and Pataday, by gender? *:

female:

Infusion related reaction
Insomnia (sleeplessness)
Local swelling (swelling at the site of some application of substance or injury)
Nasal oedema (fluid collection in nose)
Nasopharyngitis (inflammation of the nasopharynx)
Nephrolithiasis (calculi in the kidneys)
Obesity (having too much body fat)
Pain
Parkinsonism (degenerative disorder of the central nervous system characterized by tremor and impaired muscular coordination)
Poor peripheral circulation

male:

Anxiety
Emotional distress
Osteopenia (a condition where bone mineral density is lower than normal)
Osteoporosis (bones weak and more likely to break)
Renal failure (kidney dysfunction)
Tendon rupture (tear of tendon)
Headache (pain in head)
Parkinson's disease
Renal injury (kidney injury)
Anaemia (lack of blood)

What are the common drug interactions of Abilify and Pataday, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Seizure (abnormal excessive or synchronous neuronal activity in the brain)

10-19:

Arthralgia (joint pain)
Asthenia (weakness)
Asthma
Cardiac disorder
Cerebral venous thrombosis (clot in brains venous blood system)
Corneal degeneration (abnormal deposition of substances in the transparent front part of the eye)
Dizziness
Dysstasia (difficulty in standing)
Extrasystoles
Fatigue (feeling of tiredness)

20-29:

Suicidal ideation

30-39:

Central nervous system lesion (an abnormality in tissue of brain or spinal cord)
Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
Confusional state
Visual impairment

40-49:

Anxiety
Emotional distress
Hip fracture
Pain
Anaemia (lack of blood)
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Ankle fracture
Bedridden
Blood creatinine increased
Chronic kidney disease

50-59:

Arthralgia (joint pain)
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Back pain
Bedridden
Blood creatinine increased
Blood glucose increased
Chronic kidney disease
Decreased appetite
Diarrhoea
Emotional distress

60+:

Chronic kidney disease
Drug ineffective
Erythema (redness of the skin)
Eye pain
Trichorrhexis (a condition in which the hairs break)

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 21 people, 44.68%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 10 people, 21.28%
Pain: 8 people, 17.02%
High Blood Pressure: 7 people, 14.89%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 14.89%
High Blood Cholesterol: 7 people, 14.89%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 7 people, 14.89%
Asthma: 6 people, 12.77%
Insomnia (sleeplessness): 5 people, 10.64%
Stress And Anxiety: 5 people, 10.64%

* Approximation only. Some reports may have incomplete information.

Do you take Abilify and Pataday?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously